What Weak Earnings At Goldman Sachs And J.P. Morgan Mean For Biotech
Posted: Apr 22nd, 2016In: Opinions & FeaturesThis week Goldman Sachs announced that its profits fell 60% in a single quarter and blamed a volatile market that’s hit it across business lines.
Read More about What Weak Earnings At Goldman Sachs And J.P. Morgan Mean For BiotechTheranos Debacle May Scare Investors Away From Diagnostic Technology
Posted: Apr 13th, 2016In: Opinions & FeaturesNow that Theranos faces the prospect of a crippling ban on its operations by federal officials, let’s get past its implosion and talk about the real implications for the rest of the diagnostic sector.
Read More about Theranos Debacle May Scare Investors Away From Diagnostic Technology